Paola S.
- Country
- Italy
- Department
- N/A
Research Overview
- Efficacy of Eptinezumab as Adjunctive Therapy in Preventing Migraine and Treating Medication Overuse Headache in Patients with Dual Diagnosis
- Efficacy, Safety, and Tolerability of Atogepant in the Preventive Treatment of Menstrual Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 11 of 100 partner sites.
Specializations
Migraine Management
The investigator specializes in treating various forms of migraine disorders, with particular emphasis on chronic migraine and medication overuse headache (MOH). Their research encompasses preventive treatment approaches using innovative therapeutic agents.
- Chronic Migraine Prevention
- Medication Overuse Headache Treatment
- Preventive Therapy Development
Their work includes evaluating novel therapeutic options for patients with complex migraine presentations.
Women's Neurological Health
The investigator focuses on gender-specific neurological conditions, particularly menstrual migraine. Their research aims to advance understanding and treatment of hormone-related headache disorders affecting women.
- Menstrual Migraine Prevention
- Hormonal Headache Management
- Gender-Specific Treatment Approaches
Their expertise extends to developing targeted preventive treatments for menstrually-related headache disorders.
Therapeutic Innovation
The investigator evaluates novel preventive treatments for various migraine subtypes. Their work involves assessing new therapeutic agents including targeted preventive medications for specific migraine patterns.
- Innovative Treatment Protocols
- Preventive Medicine Development
- Treatment Efficacy Assessment
Their research contributes to expanding therapeutic options for patients with various migraine presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.